Strategic Partnerships Recent partner announcements in the UK & Ireland and with Innokas Medical indicate a growing channel strategy. Leverage these relationships to propose expanded SGRT deployments, joint commercialization of Catalyst+HD and Sentinel 4DCT, and regional service support packages.

Global Expansion With a history of international collaborations and a global patient impact, there is an opportunity to upsell to clinics expanding their radiotherapy programs, especially in regions where partnerships exist or are in negotiation, such as Europe and India.

Product Portfolio Newer systems Catalyst+HD and Sentinel 4DCT suggest a move toward advanced surface-guided imaging and 4D tracking. Position upgrades or bundles that combine SGRT with motion management and workflow optimization to existing sites seeking precision and efficiency gains.

Market Positioning Industry peers range from mid to large players; C-RAD operates with smaller headcount relative to revenue scales. Highlight opportunities for mid-market clinics seeking high-precision SGRT to differentiate care without large capital commitments.

Clinical Impact SGRT focus supports safer, more accurate radiotherapy and reduced side effects. Create value propositions around patient throughput, reduced treatment times, and improved safety metrics to drive conversations with clinic administrators and procurement teams.